Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lupus or SLE”

104 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 104 results

Early research (Phase 1)Study completedNCT00010335
What this trial is testing

Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders

Who this might be right for
Systemic SclerosisSystemic Lupus ErythematosusDermatomyositis+2 more
Fred Hutchinson Cancer Center 6
Early research (Phase 1)Study completedNCT02306629
What this trial is testing

Study to Compare Properties of Epratuzumab When Given as an Injection Under the Skin or Directly Into the Blood

Who this might be right for
Systemic Lupus Erythematosus
UCB Biopharma S.P.R.L. 42
Testing effectiveness (Phase 2)Ended earlyNCT05781750
What this trial is testing

Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE)

Who this might be right for
Lupus Nephritis
Kezar Life Sciences, Inc. 84
Testing effectiveness (Phase 2)Study completedNCT00976300
What this trial is testing

Cyclosporine A or Intravenous Cyclophosphamide for Lupus Nephritis: The Cyclofa-Lune Study

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis
Institute of Rheumatology, Prague 40
Not applicableStudy completedNCT04963881
What this trial is testing

Antiphospholipid Antibodies in Patients of Antiphospholipid Syndrome (APS) With Systemic Lupus Erythematosus (SLE).

Who this might be right for
Anti-phospholipid Antibobodies in Patients of SLE Presenting With Thrombosis or Pregnancy Complications
Fatima Memorial Hospital 60
Large-scale testing (Phase 3)Ended earlyNCT02041091
What this trial is testing

Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus

Who this might be right for
Lupus Erythematosus, Systemic
Eli Lilly and Company 226
Testing effectiveness (Phase 2)Study completedNCT01031836
What this trial is testing

Evaluate Safety and Tolerability of IV or SC Dose of MEDI-545 in Patients With Systemic Lupus Erythematosus.

Who this might be right for
Systemic Lupus Erythematosus
AstraZeneca 30
Large-scale testing (Phase 3)UnknownNCT05686746
What this trial is testing

Use of Baricitenib to Maintain of Remission

Who this might be right for
Lupus or SLENephritis
Assiut University 80
Early research (Phase 1)Study completedNCT04128579
What this trial is testing

Study of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative Nephritis

Who this might be right for
Lupus ErythematosusLupus Nephritis
Equillium 52
Not applicableUnknownNCT01952275
What this trial is testing

Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases

Who this might be right for
Other Specified Inflammatory Disorders of Skin or Subcutaneous TissuePyoderma GangrenosumErosive Pustular Dermatosis of the Scalp+25 more
University of Zurich 600
Large-scale testing (Phase 3)Looking for participantsNCT07332481
What this trial is testing

Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease

Who this might be right for
Systemic Lupus Erythematosus (SLE)Cutaneous Lupus Erythematosus (CLE)
EMD Serono Research & Development Institute, Inc. 202
Large-scale testing (Phase 3)Ended earlyNCT00626197
What this trial is testing

Evaluate Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus (BELONG)

Who this might be right for
Lupus NephritisSystemic Lupus Erythematosus
Genentech, Inc. 381
Early research (Phase 1)Looking for participantsNCT07109986
What this trial is testing

UB-VV410 in Subjects With Active Refractory Systemic Lupus Erythematosus or Lupus Nephritis

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis
Nanjing IASO Biotechnology Co., Ltd. 21
Testing effectiveness (Phase 2)Looking for participantsNCT06625671
What this trial is testing

A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE Participants

Who this might be right for
Systemic Lupus Erythematosus (SLE)
DualityBio Inc. 148
Testing effectiveness (Phase 2)Ended earlyNCT02080195
What this trial is testing

Nonmyeloablative Conditioning and Transplantation for Patients With Refractory Systemic Lupus Erythematosus (SLE)

Who this might be right for
Lupus ErythematosusGraft-versus-host Disease
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1
Large-scale testing (Phase 3)Study completedNCT01597622
What this trial is testing

BEL114333, a Continuation Study of BEL113750 in Subjects With Systemic Lupus Erythematosus (SLE) in Northeast Asia, and in Japan Subjects Completing the Open-label Extension of HGS1006-C1115

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 142
Large-scale testing (Phase 3)Study completedNCT05001737
What this trial is testing

Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE

Who this might be right for
Macrophage Activation SyndromeSecondary Hemophagocytic LymphohistiocytosisStill Disease+4 more
Swedish Orphan Biovitrum 33
Testing effectiveness (Phase 2)WithdrawnNCT00230035
What this trial is testing

Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST)

Who this might be right for
Systemic Lupus Erythematosus
National Institute of Allergy and Infectious Diseases (NIAID)
Early research (Phase 1)Looking for participantsNCT05869955
What this trial is testing

CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)

Who this might be right for
Systemic Lupus ErythematosusIdiopathic Inflammatory MyopathySystemic Sclerosis+1 more
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 270
Not applicableStudy completedNCT02782039
What this trial is testing

Register of Patients With Anti-Phospholipids Syndrome (APS) and/or Systemic Lupus Erythematosus (SLE)

Who this might be right for
Anti-Phospholipids Syndrome (APS)Systemic Lupus Erythematosus (SLE)
Assistance Publique - Hôpitaux de Paris 868
Load More Results